CN101536981B — 一种盐酸可乐定多囊脂质体及其制备方法
Assigned to Shanghai Institute of Pharmaceutical Industry · Expires 2010-11-17 · 15y expired
What this patent protects
本发明公开了一种盐酸可乐定多囊脂质体及其制备方法。本发明盐酸可乐定多囊脂质体包括下列重量份的各组分:活性成分盐酸可乐定1份、脂质成分1~10份、酸调节剂0.1~3.5份、渗透压调节剂10~50份和赖氨酸1.0~6.0份,其中脂质成分中包括摩尔比为1∶0.5~1∶2的中性磷脂和胆固醇,以及在脂质成分中占摩尔百分比为1%~2%的中性脂质。本发明的盐酸可乐定多囊脂质体具有较高的包封率和稳定性,在体内、体外试验中均显示有良好的缓释作用。
USPTO Abstract
本发明公开了一种盐酸可乐定多囊脂质体及其制备方法。本发明盐酸可乐定多囊脂质体包括下列重量份的各组分:活性成分盐酸可乐定1份、脂质成分1~10份、酸调节剂0.1~3.5份、渗透压调节剂10~50份和赖氨酸1.0~6.0份,其中脂质成分中包括摩尔比为1∶0.5~1∶2的中性磷脂和胆固醇,以及在脂质成分中占摩尔百分比为1%~2%的中性脂质。本发明的盐酸可乐定多囊脂质体具有较高的包封率和稳定性,在体内、体外试验中均显示有良好的缓释作用。
Drugs covered by this patent
- Camptosar (Irinotecan Hydrochloride) · Pfizer
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.